Study of VYD2311 for the Prevention of COVID-19

NCT07298434 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1770

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: VYD2311-SD
DRUG: VYD2311-MD
DRUG: Placebo

Sponsor

Invivyd, Inc.